Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies

E-ISSN： 1875-5607|11|6|519-527

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.11, Iss.6, 2011-06, pp. : 519-527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2075-2084

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors

By Price Steve Dyke Hazel J

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 7, 2007-07 ,pp. : 745-765

Informa Healthcare

Access to resources Recommend Favorite

Macrocyclic Histone Deacetylase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1423-1440

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Histone Deacetylase Inhibitors for the Treatment of Pediatric Brain Tumors

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 14, Iss. 2, 2014-09 ,pp. : 90-95

Bentham Science Publishers

Access to resources Recommend Favorite

New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 734-744

Bentham Science Publishers

Access to resources Recommend Favorite